Related Experiment Video
Updated: Dec 13, 2025
06:09
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
22.9K
Physiological and pathological functions of LRRK2: implications from substrate proteins.
Miho Araki1, Genta Ito2, Taisuke Tomita1,2
1Laboratory of Neuropathology and Neuroscience, Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Neuronal Signaling
|July 28, 2020
Summary
Leucine-rich repeat kinase 2 (LRRK2) is linked to Parkinson's disease (PD). This review explores LRRK2's roles in PD pathogenesis and neurodegeneration mechanisms, including its substrates.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Leucine-rich repeat kinase 2 (LRRK2) is a key protein implicated in Parkinson's disease (PD) pathogenesis.
- PD is a neurodegenerative disorder characterized by motor dysfunction and dopaminergic neuron loss.
Purpose of the Study:
- To review current findings on the physiological and pathological functions of LRRK2.
- To discuss the molecular mechanisms underlying LRRK2-associated neurodegeneration in PD.
Main Methods:
- Literature review of recent research on LRRK2.
- Analysis of LRRK2's functional domains and mutations (e.g., G2019S).
- Examination of LRRK2's substrate proteins, such as Rab GTPases and tau.
Main Results:
- The G2019S mutation increases LRRK2 kinase activity, suggesting a role in PD.
- Several substrate proteins of LRRK2 have been identified, but their role in neurodegeneration is unclear.
- Abnormal LRRK2 kinase activity is a suspected contributor to PD pathology.
Conclusions:
- Understanding LRRK2's precise functions is crucial for elucidating PD pathogenesis.
- Further research is needed to determine if excessive substrate phosphorylation by LRRK2 causes neurodegeneration.
- This review synthesizes current knowledge on LRRK2's role in PD and potential neurodegenerative pathways.
Related Concept Videos
01:22Lysosomal Hydrolases
4.3K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.3K
01:22PI3K/mTOR/AKT Signaling Pathway
5.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.0K
02:54Protein Kinases and Phosphatases
14.5K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
14.5K
00:49Ligand Binding and Linkage
5.3K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.3K
01:19Allosteric Proteins-ATCase
6.3K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.3K
01:31Regulation of the Unfolded Protein Response
2.8K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.8K